Delaware
|
0-33169
|
13-4066229
|
(State or Other Jurisdiction
|
(Commission
|
(I.R.S. Employer
|
of Incorporation)
|
File Number)
|
Identification No.)
|
(a)
|
On May 1, 2013, the Company held its Annual Meeting of Stockholders (“Annual Meeting").
|
(b)
|
The following items of business were voted upon by stockholders at the Annual Meeting:
|
Director
|
For
|
Against
|
Withheld
|
Broker
Non-votes
|
|||||
Joseph A. Boshart
|
25,559,658
|
0
|
1,589,246
|
2,093,970
|
|||||
Emil Hensel
|
25,255,914
|
0
|
1,892,990
|
2,093,970
|
|||||
W. Larry Cash
|
25,562,009
|
0
|
1,586,895
|
2,093,970
|
|||||
Thomas C. Dircks
|
25,475,683
|
0
|
1,673,221
|
2,093,970
|
|||||
Gale Fitzgerald
|
25,358,582
|
0
|
1,790,322
|
2,093,970
|
|||||
William J. Grubbs
|
26,404,782
|
0
|
744,122
|
2,093,970
|
|||||
Richard M. Mastaler
|
26,596,518
|
0
|
552,386
|
2,093,970
|
|||||
Joseph Trunfio
|
26,503,745
|
0
|
645,159
|
2,093,970
|
|||||
(ii)
|
To re-approve the Code Section 162(m) performance goals under the Company’s 2007 Stock Incentive Plan
|
For
|
Against
|
Abstentions
|
Broker Non-Votes
|
|||||
26,892,863
|
255,541
|
500
|
2,093,970
|
(iii)
|
To ratify the appointment of Ernst & Young LLP as the company’s independent registered public accounting firm for the fiscal year ending December 31, 2012 was approved as follows:
|
For
|
Against
|
Abstentions
|
Broker Non-Votes
|
|||||
28,912,889
|
329,585
|
400
|
0
|
(iv)
|
The compensation of named executive officers was approved, on an advisory (non-binding) basis, by the votes set forth below:
|
For
|
Against
|
Abstentions
|
Broker Non-Votes
|
|||||
26,799,995
|
345,170
|
3,739
|
2,093,970
|
|
CROSS COUNTRY HEALTHCARE, INC.
|
|
|
||
By:
|
/s/ Emil Hensel | |
Emil Hensel
Chief Financial Officer
|
||